Clarivate completes sale of Life Sciences business
- Sold Life Sciences and Healthcare business for $600 million
- Received $488.4 million in cash at close
- Pro forma financials show adjusted assets of $9.68 billion
Every EDGAR filing for CLARIVATE PLC (CLVT), newest first, with AI summaries and stories.
Next: earnings expected ~Oct 30 · 10-Q expected ~Oct 30 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 7 grants or exercises.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Henry Levy, reporting
Andrew Miles Snyder, insider filing for CLVT
Andrew Miles Snyder
Michael M Easton, insider filing for CLVT
Michael M Easton, reporting
Tov Matitiahu S. Shem, insider filing for CLVT
Tov Matitiahu S. Shem, reporting
Matthew J. Lisowski, new insider at CLVT
Matthew J. Lisowski, reporting
Kenneth L. Cornick, insider filing for CLVT
Kenneth L. Cornick, reporting
Andrew Miles Snyder, insider filing for CLVT
Andrew Miles Snyder, reporting
Andrew Miles Snyder, planned sale of CLVT shares
Andrew Miles Snyder, reporting
Jane L Okun Bomba, insider filing for CLVT
Jane L Okun Bomba, reporting
Simon Webster, insider filing for CLVT
Simon Webster, reporting
Simon Webster, new insider at CLVT
Simon Webster, reporting
Jane L Okun Bomba, insider filing for CLVT
Jane L Okun Bomba, reporting
Ownership stake disclosure by Clarkston Capital Partners, LLC (amended)
Clarkston Capital Partners, LLC, filed by
Henry Levy, insider filing for CLVT
Henry Levy, reporting
Kenneth L. Cornick, insider filing for CLVT
Kenneth L. Cornick, reporting
Michael M Easton, insider filing for CLVT
Michael M Easton, reporting